Austria (AT)

Increasing control over biomineralization in conodont evolution (2024) Shirley B, Leonhard I, Murdock DJ, Repetski J, Świś P, Bestmann M, Trimby P, et al. Journal article Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials (2024) Peyrin‐Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola , Jahnsen J, et al. Journal article Correction to: Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study (BMC Cancer, (2024), 24, 1, (320), 10.1186/s12885-024-12053-8) (2024) Kollerits B, Gruber S, Steinbrenner I, Schwaiger JP, Weissensteiner H, Schönherr S, Forer L, et al. Journal article, Erratum NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimers (2024) Guzman J, Weigelt K, Neumann AD, Tripal P, Schmid B, Winter Z, Palmisano R, et al. Journal article Comparison of T-POD and SAM Pelvic Sling II and the influence of attachment level in the initial management of unstable pelvic type C injuries – a cadaveric study (2024) Privalov M, Junge M, Jung MK, Vetter SY, Franke J, Hetjens S, Grützner PA, Stadthalter H Journal article Correction to: An 8-week injury prevention exercise program combined with change-of-direction technique training limits movement patterns associated with anterior cruciate ligament injury risk (Scientific Reports, (2024), 14, 1, (3115), 10.1038/s41598-024-53640-w) (2024) Mohr M, Federolf P, Heinrich D, Nitschke M, Raschner C, Scharbert J, Koelewijn A Journal article, Erratum Bi-allelic variants in CELSR3 are implicated in central nervous system and urinary tract anomalies (2024) Stegmann JD, Kalanithy JC, Dworschak GC, Ishorst N, Mingardo E, Lopes FM, Ho YM, et al. Journal article Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study (2024) Kollerits B, Gruber S, Steinbrenner I, Schwaiger JP, Weissensteiner H, Schönherr S, Forer L, et al. Journal article A smartphone application to reduce problematic drinking: a feasibility trial (2024) Lukas C, Blechert J, Berking M Journal article Publisher Correction: Determinants of exposure to acrylamide in European children and adults based on urinary biomarkers: results from the “European Human Biomonitoring Initiative” HBM4EU participating studies (Scientific Reports, (2023), 13, 1, (21291), 10.1038/s41598-023-48738-6) (2024) F. Fernández S, Poteser M, Govarts E, Pardo O, Coscollà C, Schettgen T, Vogel N, et al. Journal article, Erratum